Bandaríkin - enska - NLM (National Library of Medicine)

sandoz inc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg in 1 ml - granisetron hydrochloride injection, usp is a serotonin-3 (5-ht3 ) receptor antagonist indicated for: granisetron hydrochloride injection is contraindicated in patients with known hypersensitivity (e.g. anaphylaxis, shortness of breath, hypotension, urticaria) to the drug or to any of its components. pregnancy category b reproduction studies have been performed in pregnant rats at intravenous doses up to 9 mg/kg/day (54 mg/m2 /day, 146 times the recommended human dose based on body surface area) and pregnant rabbits at intravenous doses up to 3 mg/kg/day (35.4 mg/m2 /day, 96 times the recommended human dose based on body surface area) and have revealed no evidence of impaired fertility or harm to the fetus due to granisetron. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. benzyl alcohol may cross the placenta. granisetron hydrochlori

Kanada - franska - Health Canada

sandoz canada incorporated - granisétron (chlorhydrate de granisétron) - liquide - 1mg - granisétron (chlorhydrate de granisétron) 1mg - 5-ht3 receptor antagonists

Kanada - franska - Health Canada

sandoz canada incorporated - granisétron (chlorhydrate de granisétron) - solution - 1mg - granisétron (chlorhydrate de granisétron) 1mg - 5-ht3 receptor antagonists

Kanada - enska - Health Canada

sandoz canada incorporated - granisetron (granisetron hydrochloride) - solution - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists

Kanada - enska - Health Canada

sandoz canada incorporated - granisetron (granisetron hydrochloride) - liquid - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists

Singapúr - enska - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - granisetron hydrochloride 1.12mg eqv to granisetron - injection, solution - granisetron hydrochloride 1.12mg eqv to granisetron 1mg/ml

Kanada - franska - Health Canada

strides pharma canada inc - granisétron (chlorhydrate de granisétron) - solution - 1mg - granisétron (chlorhydrate de granisétron) 1mg - 5-ht3 receptor antagonists

Bandaríkin - enska - NLM (National Library of Medicine)

orchidpharma inc - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride tablets are indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Bandaríkin - enska - NLM (National Library of Medicine)

northstar rx llc - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride tablets are indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Bandaríkin - enska - NLM (National Library of Medicine)

ascend laboratories, llc - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride 1 mg - granisetron hcl is indicated for the prevention of :  - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin.  - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hcl is contraindicated in patients with known hypersensitivity to the drug or any of its components.